Scot Michael Elder - 09 Aug 2026 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Aug 2026, 17:30:03 UTC
Prior SEC filing
11 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lisa Taylor as Attorney-in-fact for Scot Elder

Key filing fact

Scot Michael Elder filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 12 Aug 2026.

Key facts

  • This page summarizes Scot Michael Elder's Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Aug 2026, 17:30.

Change

  • Previous filing in this sequence was filed on 11 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001916619 Primary reporting owner

Elder Scot Michael

Relationship
Chief Legl & Comp Off, CorpSec
Address
C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA
Signature
/s/ Lisa Taylor as Attorney-in-fact for Scot Elder
Signature date
12 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMCI transaction

Common Stock

Tax liability

Transaction value
Shares
-16,253
Change %
-2%
Price
$0.000000*
Shares after
778,683
Date
09 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 590,697 restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .